Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion

themarketherald2022-02-25

Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.

The company will issue about 72.4 million new shares at a price of 6.9 cents each.

This issue price represents a 10.4 per cent discount to the last closing price.

Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.

The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.

It will also be used for general working capital, product development initiatives, and other opportunities.

Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.

“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.

“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.

“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”

Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

yattreblif
2022-02-25
yattreblif
Ok
Shishir
2022-02-25
Shishir
Good
candyysk
2022-02-25
candyysk
Ok
TriciaChang
2022-02-25
TriciaChang
K
joot
2022-02-25
joot
Good
kevinlaisq
2022-02-25
kevinlaisq
Pls like

Leave a comment

116

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1114614812?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-02-25 13:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114614812","market":"other","top_or_hot":-1,"title":"Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion","media":"themarketherald","content":"<html><head></head><body><p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.</p><p>The company will issue about 72.4 million new shares at a price of 6.9 cents each.</p><p>This issue price represents a 10.4 per cent discount to the last closing price.</p><p>Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.</p><p>The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.</p><p>It will also be used for general working capital, product development initiatives, and other opportunities.</p><p>Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.</p><p>“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.</p><p>“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.</p><p>“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”</p><p>Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.</p></body></html>","source":"lsy1645077863021","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCreso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-25 13:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/><strong>themarketherald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each....</p>\n\n<a href=\"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CPH.AU","symbol_name":"Creso Pharma","start_time":0,"source_url":"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/","article_id":"1114614812","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114614812","pubTimestamp":1645768336,"columns":[],"sourceInfo":{"source_id":"lsy1645077863021","name":"themarketherald"},"weMediaInfo":null,"summary":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress","collect":0,"end_time":0,"defaultTopTitle":"themarketherald.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"CPH.AU":"Creso Pharma"},"translate_title":"克雷索制药（ASX：CPH）获得承诺，为美国扩张筹集500万美元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CPH.AU":0.9},"content_text":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each.This issue price represents a 10.4 per cent discount to the last closing price.Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.It will also be used for general working capital, product development initiatives, and other opportunities.Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":9030461030,"gmtCreate":1645788033304,"gmtModify":1676534064293,"author":{"id":"4090156416829480","authorId":"4090156416829480","name":"yattreblif","avatar":"https://static.tigerbbs.com/0c09ba70f4dad4731020c2b9c484a4da","vip":1,"crmLevel":12,"crmLevelSwitch":0,"idStr":"4090156416829480","authorIdStr":"4090156416829480"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030461030","repostId":1114614812,"repostType":4,"repost":{"id":"1114614812","kind":"news","pubTimestamp":1645768336,"share":"https://ttm.financial/m/news/1114614812?lang=&edition=fundamental","pubTime":"2022-02-25 13:52","market":"other","language":"en","title":"Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1114614812","media":"themarketherald","summary":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress","content":"<html><head></head><body><p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.</p><p>The company will issue about 72.4 million new shares at a price of 6.9 cents each.</p><p>This issue price represents a 10.4 per cent discount to the last closing price.</p><p>Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.</p><p>The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.</p><p>It will also be used for general working capital, product development initiatives, and other opportunities.</p><p>Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.</p><p>“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.</p><p>“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.</p><p>“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”</p><p>Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.</p></body></html>","source":"lsy1645077863021","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCreso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-25 13:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/><strong>themarketherald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each....</p>\n\n<a href=\"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CPH.AU":"Creso Pharma"},"source_url":"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114614812","content_text":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each.This issue price represents a 10.4 per cent discount to the last closing price.Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.It will also be used for general working capital, product development initiatives, and other opportunities.Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.","news_type":1,"symbols_score_info":{"CPH.AU":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9030432851,"gmtCreate":1645780091528,"gmtModify":1676534063609,"author":{"id":"3577771722524346","authorId":"3577771722524346","name":"Shishir","avatar":"https://static.tigerbbs.com/5bbb5ffb9814e2b46f518ffcbf85ff64","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":11,"crmLevelSwitch":1,"idStr":"3577771722524346","authorIdStr":"3577771722524346"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030432851","repostId":1114614812,"repostType":4,"repost":{"id":"1114614812","kind":"news","pubTimestamp":1645768336,"share":"https://ttm.financial/m/news/1114614812?lang=&edition=fundamental","pubTime":"2022-02-25 13:52","market":"other","language":"en","title":"Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1114614812","media":"themarketherald","summary":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress","content":"<html><head></head><body><p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.</p><p>The company will issue about 72.4 million new shares at a price of 6.9 cents each.</p><p>This issue price represents a 10.4 per cent discount to the last closing price.</p><p>Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.</p><p>The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.</p><p>It will also be used for general working capital, product development initiatives, and other opportunities.</p><p>Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.</p><p>“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.</p><p>“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.</p><p>“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”</p><p>Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.</p></body></html>","source":"lsy1645077863021","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCreso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-25 13:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/><strong>themarketherald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each....</p>\n\n<a href=\"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CPH.AU":"Creso Pharma"},"source_url":"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114614812","content_text":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each.This issue price represents a 10.4 per cent discount to the last closing price.Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.It will also be used for general working capital, product development initiatives, and other opportunities.Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.","news_type":1,"symbols_score_info":{"CPH.AU":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9030497931,"gmtCreate":1645777447640,"gmtModify":1676534063455,"author":{"id":"4097376940126320","authorId":"4097376940126320","name":"candyysk","avatar":"https://static.itradeup.com/news/64f60d94f5bea7832236facc0943ab72","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4097376940126320","authorIdStr":"4097376940126320"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030497931","repostId":1114614812,"repostType":4,"repost":{"id":"1114614812","kind":"news","pubTimestamp":1645768336,"share":"https://ttm.financial/m/news/1114614812?lang=&edition=fundamental","pubTime":"2022-02-25 13:52","market":"other","language":"en","title":"Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1114614812","media":"themarketherald","summary":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress","content":"<html><head></head><body><p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.</p><p>The company will issue about 72.4 million new shares at a price of 6.9 cents each.</p><p>This issue price represents a 10.4 per cent discount to the last closing price.</p><p>Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.</p><p>The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.</p><p>It will also be used for general working capital, product development initiatives, and other opportunities.</p><p>Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.</p><p>“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.</p><p>“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.</p><p>“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”</p><p>Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.</p></body></html>","source":"lsy1645077863021","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCreso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-25 13:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/><strong>themarketherald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each....</p>\n\n<a href=\"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CPH.AU":"Creso Pharma"},"source_url":"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114614812","content_text":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each.This issue price represents a 10.4 per cent discount to the last closing price.Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.It will also be used for general working capital, product development initiatives, and other opportunities.Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.","news_type":1,"symbols_score_info":{"CPH.AU":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9030496507,"gmtCreate":1645775728222,"gmtModify":1676534063361,"author":{"id":"3560421500323385","authorId":"3560421500323385","name":"TriciaChang","avatar":"https://static.tigerbbs.com/5cb6619edb253a8bb8b2776c7d9b0e02","vip":1,"crmLevel":12,"crmLevelSwitch":0,"idStr":"3560421500323385","authorIdStr":"3560421500323385"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030496507","repostId":1114614812,"repostType":4,"repost":{"id":"1114614812","kind":"news","pubTimestamp":1645768336,"share":"https://ttm.financial/m/news/1114614812?lang=&edition=fundamental","pubTime":"2022-02-25 13:52","market":"other","language":"en","title":"Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1114614812","media":"themarketherald","summary":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress","content":"<html><head></head><body><p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.</p><p>The company will issue about 72.4 million new shares at a price of 6.9 cents each.</p><p>This issue price represents a 10.4 per cent discount to the last closing price.</p><p>Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.</p><p>The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.</p><p>It will also be used for general working capital, product development initiatives, and other opportunities.</p><p>Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.</p><p>“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.</p><p>“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.</p><p>“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”</p><p>Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.</p></body></html>","source":"lsy1645077863021","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCreso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-25 13:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/><strong>themarketherald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each....</p>\n\n<a href=\"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CPH.AU":"Creso Pharma"},"source_url":"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114614812","content_text":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each.This issue price represents a 10.4 per cent discount to the last closing price.Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.It will also be used for general working capital, product development initiatives, and other opportunities.Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.","news_type":1,"symbols_score_info":{"CPH.AU":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9030496033,"gmtCreate":1645775378269,"gmtModify":1676534063346,"author":{"id":"4087214231800470","authorId":"4087214231800470","name":"joot","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"4087214231800470","authorIdStr":"4087214231800470"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030496033","repostId":1114614812,"repostType":4,"repost":{"id":"1114614812","kind":"news","pubTimestamp":1645768336,"share":"https://ttm.financial/m/news/1114614812?lang=&edition=fundamental","pubTime":"2022-02-25 13:52","market":"other","language":"en","title":"Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1114614812","media":"themarketherald","summary":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress","content":"<html><head></head><body><p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.</p><p>The company will issue about 72.4 million new shares at a price of 6.9 cents each.</p><p>This issue price represents a 10.4 per cent discount to the last closing price.</p><p>Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.</p><p>The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.</p><p>It will also be used for general working capital, product development initiatives, and other opportunities.</p><p>Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.</p><p>“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.</p><p>“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.</p><p>“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”</p><p>Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.</p></body></html>","source":"lsy1645077863021","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCreso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-25 13:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/><strong>themarketherald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each....</p>\n\n<a href=\"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CPH.AU":"Creso Pharma"},"source_url":"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114614812","content_text":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each.This issue price represents a 10.4 per cent discount to the last closing price.Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.It will also be used for general working capital, product development initiatives, and other opportunities.Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.","news_type":1,"symbols_score_info":{"CPH.AU":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9030490269,"gmtCreate":1645773777299,"gmtModify":1676534063248,"author":{"id":"3572874548548490","authorId":"3572874548548490","name":"kevinlaisq","avatar":"https://static.tigerbbs.com/329de1199f764a89b7cadf50308e183d","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3572874548548490","authorIdStr":"3572874548548490"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030490269","repostId":1114614812,"repostType":4,"repost":{"id":"1114614812","kind":"news","pubTimestamp":1645768336,"share":"https://ttm.financial/m/news/1114614812?lang=&edition=fundamental","pubTime":"2022-02-25 13:52","market":"other","language":"en","title":"Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1114614812","media":"themarketherald","summary":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress","content":"<html><head></head><body><p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.</p><p>The company will issue about 72.4 million new shares at a price of 6.9 cents each.</p><p>This issue price represents a 10.4 per cent discount to the last closing price.</p><p>Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.</p><p>The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.</p><p>It will also be used for general working capital, product development initiatives, and other opportunities.</p><p>Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.</p><p>“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.</p><p>“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.</p><p>“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”</p><p>Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.</p></body></html>","source":"lsy1645077863021","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Creso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCreso Pharma (ASX:CPH) Secures Commitments to Raise $5M for US Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-25 13:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/><strong>themarketherald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each....</p>\n\n<a href=\"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CPH.AU":"Creso Pharma"},"source_url":"https://themarketherald.com.au/creso-pharma-asxcph-secures-commitments-to-raise-5m-for-us-expansion-2022-02-25/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114614812","content_text":"Creso Pharma (CPH) has received firm commitments to raise $5 million through a placement to progress its US expansion.The company will issue about 72.4 million new shares at a price of 6.9 cents each.This issue price represents a 10.4 per cent discount to the last closing price.Participants of the placement will also receive one attaching option for every share, which will be exercisable at 14 cents each and expire after 18 months.The funds will be used to help the company grow its US footprint following the acquisition of Sierra Sage Herbs and Green Goo brand.It will also be used for general working capital, product development initiatives, and other opportunities.Chief Executive Officer and Managing Director William Lay said he is pleased with the support shown in the placement.“These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives and explore new opportunities to unlock shareholder value,” he said.“The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products and psychedelic treatments.“We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.”Shares were trading 9.09 per cent lower today at 7 cents each at 12:16 pm AEDT.","news_type":1,"symbols_score_info":{"CPH.AU":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":116,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1114614812","isCrawlerRequest":true}